Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Natus Medical Denmark ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   2.3% 2.3% 2.3% 2.3% 2.3% 2.3% 2.3% 2.3%   Bankruptcy risk   10.2% 16.3% 7.4% 9.4% 8.0% 9.1% 19.8% 19.8%   Credit score (0-100)   25 11 31 25 30 27 6 6   Credit rating   BB BB BB BB BB BB B B   Credit limit (mDKK)   -0.0 -0.0 -0.0 -0.0 -0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1.0 Income statement (mDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   436 382 328 268 175 190 190 190   Gross profit   436 382 122 164 111 125 0.0 0.0   EBITDA   -91.0 -139 -169 -164 -100 -71.2 0.0 0.0   EBIT   -91.0 -139 -169 -164 -100 -71.2 0.0 0.0   Pre-tax profit (PTP)   -82.8 -62.9 -247.7 -197.4 -81.9 -147.9 0.0 0.0   Net earnings   -82.8 -62.9 -194.2 -239.4 -81.9 -147.8 0.0 0.0   Pre-tax profit without non-rec. items   -91.0 -139 -248 -197 -81.9 -78.8 0.0 0.0     See the entire income statement 1.0 Balance sheet (mDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   0.0 0.0 7.5 7.4 6.7 6.2 0.0 0.0   Shareholders equity total   -164 -226 -421 -660 -186 -342 -424 -424   Interest-bearing liabilities   0.0 0.0 692 754 286 434 424 424   Balance sheet total (assets)   511 538 328 123 136 124 0.0 0.0   Net Debt   0.0 0.0 689 754 286 434 424 424     See the entire balance sheet 1.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   436 382 328 268 175 190 190 190   Net sales growth   -21.1% -12.3% -14.2% -18.2% -34.6% 8.3% 0.0% 0.0%   Gross profit   436 382 122 164 111 125 0.0 0.0   Gross profit growth   -21.1% -12.3% -68.1% 34.3% -32.1% 12.1% -100.0% 0.0%   Employees   150 110 88 62 68 70 0 0   Employee growth %   -5.7% -26.7% -20.0% -29.5% 9.7% 2.9% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   511 538 328 123 136 124 0 0   Balance sheet change%   -16.4% 5.4% -39.1% -62.5% 10.7% -9.0% -100.0% 0.0%   Added value   -91.0 -138.7 -169.5 -163.8 -100.2 -71.2 0.0 0.0   Added value %   -20.9% -36.3% -51.7% -61.1% -57.2% -37.5% 0.0% 0.0%   Investments   0 0 106 -52 14 13 -81 0   Net sales trend   -1.0 -2.0 -3.0 -4.0 -5.0 1.0 0.0 0.0   EBIT trend   -1.0 -2.0 -3.0 -4.0 -5.0 -5.0 0.0 0.0   1.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   -20.9% -36.3% -51.7% -61.1% -57.2% -37.5% 0.0% 0.0%   EBIT %   -20.9% -36.3% -51.7% -61.1% -57.2% -37.5% 0.0% 0.0%   EBIT to gross profit (%)   -20.9% -36.3% -139.1% -100.0% -90.1% -57.1% 0.0% 0.0%   Net Earnings %   -19.0% -16.5% -59.2% -89.3% -46.7% -77.9% 0.0% 0.0%   Profit before depreciation and extraordinary items %   -19.0% -16.5% -59.2% -89.3% -46.7% -77.9% 0.0% 0.0%   Pre tax profit less extraordinaries %   -20.9% -36.3% -75.5% -73.6% -46.7% -41.5% 0.0% 0.0%   ROA %   -14.2% -19.3% -22.1% -17.1% -11.6% -20.0% 0.0% 0.0%   ROI %   -31.2% -286.4% -45.8% -18.0% -12.3% -21.8% 0.0% 0.0%   ROE %   -38.6% 0.0% -117.4% -105.5% -63.2% -113.7% 0.0% 0.0%   1.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   -13.8% -17.4% -56.0% -84.3% -57.8% -73.4% -100.0% -100.0%   Relative indebtedness %   154.7% 200.1% 228.3% 291.7% 183.5% 245.0% 223.3% 223.3%   Relative net indebtedness %   154.7% 200.1% 227.6% 291.6% 183.4% 244.9% 223.3% 223.3%   Net int. bear. debt to EBITDA, %   0.0% 0.0% -406.7% -460.3% -285.5% -609.2% 0.0% 0.0%   Gearing %   0.0% 0.0% -164.4% -114.2% -153.6% -126.9% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 23.3% 9.2% 3.4% 0.0% 0.0% 0.0%   1.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.4 0.5 0.1 0.0 0.1 0.0 0.0 0.0   Current Ratio   0.4 0.5 0.2 0.0 0.1 0.0 0.0 0.0   Cash and cash equivalent   0.0 0.0 2.4 0.2 0.1 0.1 0.0 0.0   1.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 9.6 8.6 12.2 8.1 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   54.3% 87.2% 40.2% 7.7% 19.8% 9.2% 0.0% 0.0%   Net working capital   -375.7 -396.6 -608.3 -755.9 -281.4 -442.1 -212.0 -212.0   Net working capital %   -86.2% -103.8% -185.5% -281.9% -160.5% -232.9% -111.7% -111.7%   1.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   3 3 4 4 3 3 0 0   Added value / employee   -1 -1 -2 -3 -1 -1 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -1 -1 -2 -3 -1 -1 0 0   EBIT / employee   -1 -1 -2 -3 -1 -1 0 0   Net earnings / employee   -1 -1 -2 -4 -1 -2 0 0